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Antiretroviral therapy (ART) initiation in the community and outside of a traditional health
facility has the potential to improve linkage to ART, decongest health facilities, and minimize
structural barriers to attending HIV services among people living with HIV (PLWH). We con-
ducted a systematic review and meta-analysis to determine the effect of offering ART initia-
tion in the community on HIV treatment outcomes.
Methods and findings
We searched databases between 1 January 2013 and 22 February 2021 to identify random-
ized controlled trials (RCTs) and observational studies that compared offering ART initiation
in a community setting to offering ART initiation in a traditional health facility or alternative
community setting. We assessed risk of bias, reporting of implementation outcomes, and
real-world relevance and used Mantel–Haenszel methods to generate pooled risk ratios
(RRs) and risk differences (RDs) with 95% confidence intervals. We evaluated heterogene-
ity qualitatively and quantitatively and used GRADE to evaluate overall evidence certainty.
Searches yielded 4,035 records, resulting in 8 included studies—4 RCTs and 4 observa-
tional studies—conducted in Lesotho, South Africa, Nigeria, Uganda, Malawi, Tanzania,
and Haiti—a total of 11,196 PLWH. Five studies were conducted in general HIV populations,
2 in key populations, and 1 in adolescents. Community ART initiation strategies included
community-based HIV testing coupled with ART initiation at home or at community venues;
5 studies maintained ART refills in the community, and 4 provided refills at the health facility.
All studies were pragmatic, but in most cases provided additional resources. Few studies
reported on implementation outcomes. All studies showed higher ART uptake in community
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initiation arms compared to facility initiation and refill arms (standard of care) (RR 1.73, 95%
CI 1.22 to 2.45; RD 30%, 95% CI 10% to 50%; 5 studies). Retention (RR 1.43, 95% CI 1.32
to 1.54; RD 19%, 95% CI 11% to 28%; 4 studies) and viral suppression (RR 1.31, 95% CI
1.15 to 1.49; RD 15%, 95% CI 10% to 21%; 3 studies) at 12 months were also higher in the
community-based ART initiation arms. Improved uptake, retention, and viral suppression
with community ART initiation were seen across population subgroups—including men,
adolescents, and key populations. One study reported no difference in retention and viral
suppression at 2 years. There were limited data on adherence and mortality. Social harms
and adverse events appeared to be minimal and similar between community ART initiation
and standard of care. One study compared ART refill strategies following community ART
initiation (community versus facility refills) and found no difference in viral suppression (RD
−7%, 95% CI −19% to 6%) or retention at 12 months (RD −12%, 95% CI −23% to 0.3%).
This systematic review was limited by few studies for inclusion, poor-quality observational
data, and short-term outcomes.
Conclusions
Based on data from a limited set of studies, community ART initiation appears to result in
higher ART uptake, retention, and viral suppression at 1 year compared to facility-based
ART initiation. Implementation on a wider scale necessitates broader exploration of costs,
logistics, and acceptability by providers and PLWH to ensure that these effects are repro-
ducible when delivered at scale, in different contexts, and over time.
Author summary
Why was this study done?
• Over the last decade HIV services have increasingly moved out of the health facility and
into the community through the provision of decentralized and differentiated HIV care.
• It remains unclear however whether initiating ART in a community setting will result in
treatment and safety outcomes that are comparable to facility-based ART initiation.
What did the researchers do and find?
• We conducted a systematic review to identify studies where ART was initiated at com-
munity locations, including homes, mobile vans, or other community venues.
• We identified 8 studies (including 11,196 HIV-positive people), 7 of which were con-
ducted in sub-Saharan Africa; 4 were randomized controlled trials and 4 were cohort
studies.
• The methodological quality of the randomized controlled trials was high, but cohort
data were of poorer quality. Studies were generally pragmatic in design, but implemen-
tation outcomes were infrequently reported.
• Based on meta-analysis of this limited dataset, it appeared that ART initiation in the
community resulted in higher ART uptake, higher retention, and greater viral
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suppression at 1 year compared to facility-based ART initiation and refill, among HIV-
positive people offered ART. These findings were consistent across population sub-
groups and various implementation strategies.
• There were insufficient data on serious adverse events or mortality to draw firm conclu-
sions on these outcomes.
What do these findings mean?
• Community ART initiation may result in better outcomes than ART initiation in tradi-
tional health facilities.
• To increase the robustness of these findings, high-quality implementation research con-
ducted in diverse settings, exploring optimum combinations of community ART initia-
tion and ART refill strategies over longer time periods, will be critical.
Introduction
Initiating antiretroviral therapy (ART) in the community setting and outside of traditional
health facilities represents an innovative addition to “differentiated service delivery” models,
which seek to offer a greater range of options that meet a diversity of patient needs in the global
HIV service delivery enterprise. Community-based ART initiation has several potential bene-
fits including reducing psychological and structural barriers that newly diagnosed HIV-posi-
tive people face in order to access a facility, as well as further decongesting crowded facilities
themselves. With a shift over the last decade to rapidly initiating ART in those who test HIV-
positive, and decentralizing and differentiating follow-up after treatment initiation in the facil-
ity, community ART initiation represents the next step toward more patient-centered services
and may bridge the critical gap between testing and linkage to ART—a point in the HIV care
cascade when many disengage from care [1–3].
Despite this rationale, few studies have explored the effect of community ART initiation on
either short- or long-term outcomes. Community-based HIV testing, including mobile testing,
self-testing, testing campaigns, workplace testing, and index testing, frequently shows higher
coverage and uptake than traditional facility-based testing and has the ability to reach those
underserved by routine facility-based testing, particularly men and key populations [4,5].
Community-based medication refill for patients stable on ART, such as distribution directly to
patients’ homes or to community pick-up locations and pharmacies, has generally demon-
strated success [6,7]. ART initiation, however, has traditionally been reserved for facilities
because of the perceived intensity of the encounter, but this assumption is not empirically sup-
ported. Qualitative data suggest that the act of going to a clinic is intimidating and confusing,
particularly in environments where stigma is present—making community ART initiation a
potentially important innovation [8].
A number of studies examining the effects of community ART initiation have been con-
ducted, but synthesis and review are needed to appraise the quality of the data as well as assess
the top-line evidence of the effect of this approach on immediate and medium-term outcomes.
In addition, systematic reviews are required as a part of the guideline development processes
led by the HIV department at the World Health Organization (WHO), and therefore an
important step in the translation of evidence to practice. To explore the effect of initiating
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ART in a community setting on HIV treatment outcomes, we conducted a systematic review
that additionally characterized features of community ART initiation strategies to inform pol-
icy and implementation.
Methods
Search strategy and selection criteria
The protocol for this systematic review was registered on PROSPERO (CRD42019130272) and
followed PRISMA guidelines [9,10] (S1 Table). We searched the Cochrane Central Register of
Controlled Trials (CENTRAL, published in the Cochrane Library), MEDLINE (PubMed),
Embase (OVID), Africa-Wide Information and CINAHL (EBSCOhost), LILACS, and Web of
Science Core Collection from 1 January 2013 until 15 April 2019; this start date was based on
the 2013 WHO recommendation for decentralization of HIV treatment and care [11], and a
previous systematic review that searched for studies published from 1996 to 2013 and found
no published studies on community-based ART initiation prior to 2013 [12] (S1 Appendix).
Searches were updated on 1 April 2020 and again on 22 February 2021.
We included randomized and non-randomized study designs that enrolled HIV-positive
people of any age, conducted in low- and middle-income countries, and compared community
ART initiation to facility-based ART initiation or to another community-based ART initiation
strategy. We defined community ART initiation as initiation of ART outside of a traditional
health facility or workplace health center, by any cadre of health staff. Community settings
included, for example, mobile health services, community centers, and patients’ homes. ART
could be offered and initiated in the community and subsequently maintained in the commu-
nity or at a health center. Our comparison arm was ART initiation in a traditional health facil-
ity; ART maintenance after initiation could occur within or outside of the health facility. No
language or age restrictions were applied to the search. We additionally searched HIV/AIDS
conferences including International AIDS Society (IAS) conferences and the Conference on
Retroviruses and Opportunistic Infections (CROI) until 10 March 2021, as well as the refer-
ence lists of included studies and relevant systematic reviews. We also searched ClinicalTrials.
gov and the WHO International Clinical Trials Registry Platform for ongoing studies.
Data extraction and methodological quality assessment
Abstract and full-text screening was done in duplicate, with discrepancies resolved by a third
author. Data from included studies were abstracted by a single author (SAA) and verified by a
second author (AAA). Data were extracted in a pre-piloted data extraction tool developed in
Airtable (https://airtable.com)—a commercially available web-based relational database tool.
We extracted key characteristics of each study, including (1) study location; (2) methods: study
design, dates and duration of study and follow-up, and number and type of sites; (3) study
population: number, age, sex, and inclusion/exclusion criteria; (4) intervention and compara-
tor details; (5) outcomes: ART uptake, retention in care, viral suppression, mortality, adher-
ence, and adverse events, extracted when possible with numerators, denominators, and/or
measures of association; and (6) indicators of risk of bias. Any discrepancies were resolved by
discussion among the authors. The Cochrane or Newcastle–Ottawa Scale tools were used to
assess risk of bias [13,14].
Assessment of study implementation characteristics
We additionally characterized studies according to PRECIS-2 criteria for how pragmatic or
explanatory included studies were—exploring eligibility assessments, recruitment procedures,
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settings, organizational characteristics, flexibility in intervention delivery and adherence, fol-
low-up, primary outcome reporting, and primary analyses [15]. Although the tool is optimized
for randomized control trial (RCT) design, we applied PRECIS-2 concepts across all studies.
We also explored reporting of implementation outcomes in primary and additional study pub-
lications across 8 domains: acceptability, adoption, appropriateness, implementation cost, fea-
sibility, fidelity, adaptation, penetration, and sustainability [16].
Data synthesis and statistical analysis
For pairwise meta-analyses, we used random effects generic inverse variance meta-analytic
models; we evaluated ART uptake (initiation) among all HIV-positive individuals, and for
retention in care and viral suppression we assessed these outcomes among all who initiated
ART. We determined risk ratios (RRs) and 95% confidence intervals for all outcomes and
additionally present risk differences (RDs) where absolute effects were deemed valuable for
interpretation. For cluster randomized trials we calculated the design effect using methods out-
lined in the Cochrane handbook (where dichotomous counts from each study are divided by
the quantity 1 + [M− 1] × ICC, where M is the average cluster size and ICC is the intra-cluster
correlation coefficient) to adjust estimates if we could not incorporate adjusted estimates
directly from study publications. We used Mantel–Haenszel methods to generate pooled esti-
mates of binary data. We evaluated heterogeneity qualitatively through examining forest plots
and quantitatively through examination of the I2 statistic. Between-study variance was evalu-
ated using the Paule–Mandel estimator for Tau2 and the associated I2 statistic [17]. We used
subgroup analyses to explore heterogeneity. For each outcome, we generated forest plots over-
all and subgrouped where relevant by study design, population type, and implementation fea-
tures. We conducted tests for subgroup differences to determine if cohort and RCT data could
be pooled. R statistical software was used for all analyses [18].
Evidence appraisal
We evaluated the certainty/quality of the body of evidence contributing to the pooled effect
estimate for each outcome using criteria recommended by the GRADE Working Group,
including risk of bias, inconsistency, indirectness, imprecision, and other domains [19–22].
Results
Searches were conducted between 1 January 2013 and 22 February 2021 and yielded 4,035
abstracts for screening after deduplication. We identified 120 records for full-text screening
and 3 possibly eligible ongoing studies; 105 studies were excluded with reasons, and 15 publi-
cations representing 8 studies were included in the qualitative synthesis, with 7 studies
included in meta-analyses (Fig 1).
Four studies were RCTs, 2 individually randomized [23–25] and 2 cluster randomized
[26,27]; 3 were cohort studies with a comparison arm [28–30], and 1 study was a single-arm
cohort study [31]. Two studies were conducted in Nigeria [29,31] and Lesotho [23,27] each,
and 1 each was conducted in South Africa [25], Uganda [32], Malawi [26], Tanzania [28], and
Haiti [30]. Five studies were conducted in general populations, 2 included key population
groups, and 1 included adolescents (Table 1).
Studies incorporated several differentiated service delivery features including task shifting/
sharing and changes in the location and frequency of services (Table 2). Community ART ini-
tiation was in most cases delivered by a small team including a nurse and counselor or a village
health worker, but in some studies involved a larger team, including lab technicians, pharma-
cists, doctors, and additional community lay workers [28,29,31]. Within the community
PLOS MEDICINE Community ART initiation: A systematic review
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Fig 1. PRISMA flow diagram. CROI, Conference on Retroviruses and Opportunistic Infections; IAS, International AIDS Society; ICTRP, International Clinical
Trials Registry Platform.
https://doi.org/10.1371/journal.pmed.1003646.g001
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setting, 2 studies initiated ART in the home, and the remaining studies initiated ART at com-
munity venues (such as mobile vans, individual homes, and other community venues). All
studies paired community ART initiation with community-based HIV testing strategies. Two
studies included HIV self-testing strategies; in one this was the primary method of HIV testing
[26], and in another HIV self-tests were distributed to those who declined testing and those
away from home in a subset of participants [27]. The location of ART refill collection (after
ART initiation) varied, with half of the studies having participants collect ART refills in the
community [28,30,31] and the other half having participants collect ART refills at the health
facility [23,26,29]; Once stabilized on ART, those receiving facility-based ART refills received
ART refills every 3 months. All studies initiated ART rapidly, either on the same day as testing
(5 studies) or within 7 days (3 studies). Six comparative studies compared community ART
initiation to facility-based ART initiation, with a similar subsequent frequency of ART refills
in all except 1 study [23], where refill frequency was monthly in the facility arm compared to
every 3 months in the community arm. One comparative study compared different ART refill
strategies across 2 community ART arms [27]. In several studies, community ART initiation
strategies were also combined with additional demand creation [26,31], enhanced support
strategies [28–30], or SMS reminders [27]—beyond what was offered in the facility-based initi-
ation (standard of care) arm.
Table 1. General description of included studies.
Study Study
Design
Country Setting Number of HIV
+ participants





Rural regions 1,315 General HIV
endemic
communities
ART naïve, WHO stage 1–3, CD4 cell
count > 100/μL, not pregnant or breastfeeding,












Any CD4 cell count
Labhardt 2018
[23,33,35]
RCT Lesotho Rural northern region 274 General HIV
endemic
communities
ART naïve, WHO stage 1–3, not pregnant or






Lesotho Rural northern region 257 General HIV
endemic community
ART naïve; weight > 35 kg; no other chronic
condition; physical, mental, and emotional






Malawi Blantyre (urban center) 768 General HIV
endemic
communities
CD4 cell count < 350/μL or WHO stage 3 or 4
or pregnant or breastfeeding
Oladele 2018
[29]�
Cohort Nigeria Fourteen donor-funded
high-HIV-burden




CD4 cell count < 500/μL or WHO stage 3 or 4




Community care group: any CD4 count;
historical cohort: CD4 cell count < 350/μL
Tun 2019
[28,36]
Cohort Tanzania High HIV prevalence
(major trucking routes)
617 FSWs Any CD4 count
CRAG, cryptococcal antigen screening; FSW, female sex worker; MSM, men who have sex with men; PWID, people who inject drugs; RCT, randomized controlled trial;
TB, tuberculosis.
�Data restricted to patients testing for HIV in the community in the post-intervention period for intervention and control areas.
��Unpublished data from conference abstract only.
https://doi.org/10.1371/journal.pmed.1003646.t001
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Table 2. Intervention strategy details.
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CBO, community-based organization; CaCx, cervical cancer; FP, family planning; IPV, intimate partner violence; STI, sexually transmitted infection; TB, tuberculosis;
VHW, village health worker.
Macpherson 2014: 36% of those offered home ART in the home group chose facility ART initiation (64% selected home art initiation); Amstutz 2021: 6- and 12-month
ART refill visits were at health facility due to viral load measurement.
https://doi.org/10.1371/journal.pmed.1003646.t002
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Data from RCTs were generally judged as having high methodological quality (low risk of
bias), and observational data as having poor quality, as assessed by risk of bias tools (Table 3;
S2 Appendix). Observational studies had several methodological limitations, primarily related
to lack of comparability of study arms and inclusion of data that were not adjusted for baseline
imbalances in the pairwise meta-analysis.
We used PRECIS-2 criteria to assess how pragmatic or explanatory included studies were
(Tables 4 and S2): Overall, studies were highly pragmatic—conducted in real-world settings,
with flexible approaches to intervention delivery and few additional measures to ensure adher-
ence to ART beyond what would occur in routine practice. RCTs were on average less prag-
matic than cohort studies. Study procedures in trials that appeared less applicable in the “real
world” setting included the following: (1) more restrictive inclusion criteria that included, for
example, CD4 count measurement, or exclusion of those who were pregnant, breastfeeding, or
had chronic conditions [25,27,34]; (2) expertise and resources used to deliver the intervention,
with large, well-trained, multidisciplinary teams initiating ART in the community in some
studies [23,26], or the provision of food parcels at visits [25]; and (3) extensive patient follow-
up, where tracing efforts appeared more rigorous than what may occur in routine practice [23]
—approaches that may not be entirely reproducible at scale.
ART initiation
Seven studies reported on ART initiation after offer of community ART; ART uptake among
those testing HIV-positive was high overall (85%), but there was substantial heterogeneity of
measurement time points, and uptake across studies ranged from 37% to 100% (Fig 2). The
lowest ART uptake (37%) was seen in a study where HIV self-testing was conducted and
paired with community ART initiation [26]. A single-arm study conducted in key populations
had an overall uptake of 77%, but this varied across key population subgroups, with uptake of
Table 3. Risk of bias assessments.
Study ART uptake/initiation among
HIV+ individuals








Barnabas 2020 NA NA Low risk NA NA
Labhardt 2018 Low risk Low risk Low risk NA Some concerns
Amstutz 20211 NA Some concerns Some concerns NA Some concerns
MacPherson
2014
Low risk Low risk NA High risk Some concerns
Oladele 20182 Poor quality NA NA NA NA
Reif 20173 Poor quality Poor quality NA NA NA
Tun 20194 Poor quality Poor quality Poor quality Poor quality Poor quality
NA, not applicable.
Assessments based on Cochrane RoB 1 tool for randomized controlled trials (high risk, some concerns, low risk) or Newcastle–Ottawa Scale for cohort studies (poor
quality, good quality). Detailed assessments available in S2 Appendix.
1Allocation concealment was not possible; recruiting teams were aware of household assignments prior to recruitment; participants were, however, unaware of
assignment during recruitment.
2Comparison group (facility referral for ART initiation) very small compared to home ART group; fundamental differences between community and facility art
initiation groups (facility groups urban and with lower HIV prevalence); unadjusted numbers used in this analysis.
3Overall risk of bias influenced by different sources of comparison (historical cohort with CD4 cell count < 350/μL) and intervention group; unadjusted estimates used
in analysis without controlling for any baseline characteristics; in addition, the comparative analysis remains unpublished.
4Comparison group drawn from a different region; ascertainment of exposure not described; unadjusted estimates used in analysis; baseline imbalance in the group
characteristics; intervention group had substantially more newly diagnosed participants, which could affect uptake and retention.
https://doi.org/10.1371/journal.pmed.1003646.t003
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75% in female sex workers (FSWs), followed by men who have sex with men (68%) and people
who inject drugs (PWID) (53%); partners of key populations in this study had generally high
community ART uptake (93%) [31].
Five studies compared community ART initiation to facility-based ART initiation and refill
(standard of care). The meta-analysis of these studies showed higher ART initiation when
Table 4. PRECIS-2 criteria/score.















































4 4 5 3 4 5 5 5 5
Ibiloye 2018 5 4 5 3 5 5 3 5 5
Labhardt
2018
4 3 5 3 4 4 2 5 5
Amstutz
2021
5 4 5 3 4 5 4 5 5
MacPherson
2014
5 4 4 3 3 5 4 5 5
Oladele 2018 5 5 3 3 5 5 5 5 4
Reif 2017 5 5 4 4 5 5 4 5 4
Tun 2019 5 3 5 4 4 5 3 5 5
Value of 5 (dark green) represents a very pragmatic approach and a value of 1 (yellow) represents a very explanatory approach. Detailed assessments presented in
S2 Table.
https://doi.org/10.1371/journal.pmed.1003646.t004
Fig 2. ART uptake in community ART initiation study arms, among HIV-positive and by outcome measurement time point. Tun 2019 was conducted in
female sex workers; Ibiloye 2018 included female sex workers, men who have sex with men, people who inject drugs, and partners of individuals in these key
populations.
https://doi.org/10.1371/journal.pmed.1003646.g002
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ART was offered in the community (Fig 3; RR 1.73, 95% CI 1.22 to 2.45; I2 98%), which trans-
lated to an absolute risk difference of 30% (95% CI 10% to 50%) (S1 Fig).
When subgrouped by study design, a stronger effect was seen in RCTs (RR 2.23, 95%
CI 1.21 to 4.11) as compared to cohort studies (RR 1.48, 95% CI 1.00 to 2.20); this differ-
ence accounted for some of the heterogeneity seen in the overall analysis but not all.
There was greater heterogeneity of effect estimates among cohort studies compared to
RCTs: 2 cohort studies, one conducted in FSWs (RR 1.41, 95% CI 1.27 to 1.57) and
another in adolescents (RR 1.08, 95% CI 1.05 to 1.12), showed smaller differences in ART
uptake compared to studies conducted in general HIV endemic communities (RR 2.20,
95% CI 1.56 to 3.12) (S2 Fig). Home ART initiation (explored only in RCTs) had compa-
rable ART uptake (RR 2.23, 95% CI 1.21 to 4.11) to ART offered at other venues in the
community (RR 1.48, 95% CI 1.00 to 2.20) (S3 Fig). Same-day ART initiation (RR 1.91,
95% CI 1.05 to 3.46) showed similar ART uptake to initiation within 7 days (RR 1.45,
95% CI 1.30 to 1.62) (S4 Fig).
Retention in care
Four studies compared retention in care between community ART initiation and facility ART
initiation and maintenance (standard of care) among HIV-positive individuals at 6–12 months
[23,26,28,30]. Retention was higher in the community ART initiation group compared to the
facility ART initiation group (RR 1.43, 95% CI 1.32 to 1.54), which translated to a risk differ-
ence of 19% (95% CI 11% to 28%) (Figs 4 and S5).
When compared to standard of care (facility-based ART initiation and refills), retention
did not appear to differ by population type, ART initiation site, refill site, or frequency of ART
refill (Fig 5). One study additionally reported retention among HIV-positive individuals at 24
months and found no difference between community ART initiation and facility ART initia-
tion and maintenance (RD 5%, 95% CI −16% to 16%, p = 0.380) at this time point [33]. In
pooled analyses restricted to those who initiated ART, retention was no different between
Fig 3. ART uptake: Community ART initiation versus standard of care among HIV-positive individuals, by study design. COM, community ART
initiation; e, number of events; n, number of participants; RCT, randomized controlled trial; RR, risk ratio; SOC, standard of care. MacPherson 2014
cluster-adjusted effect estimate based on the Cochrane method of adjusting for the design effect.
https://doi.org/10.1371/journal.pmed.1003646.g003
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study arms (S6 Fig; RR 1.15, 95% CI 0.99 to 1.33). The single-arm study Ibiloye 2018 [31]
reported 73.2% retention in care among key populations of individuals who initiated ART in
the community ART arm after 7 months of follow-up.
An additional study that compared 2 community ART initiation arms reported slightly bet-
ter retention at 12 months when community ART initiation was combined with facility refills
(71%) compared to community-based ART refills (60%); this however did not reach statistical
significance (RD −12%, 95% CI −23% to 0.3%) [27].
Viral suppression
Three studies compared viral suppression between community ART initiation and facility
ART initiation and maintenance (standard of care) arms among HIV-positive individuals at
12 months; this comparison showed better viral suppression in the community ART group
(RR 1.31, 95% CI 1.15 to 1.49) (Fig 6). One study additionally reported 24-month outcomes,
which showed no difference in viral load suppression in the community ART arm compared
to the facility ART arm (RD 3%, 95% CI −9% to 15%, p = 0.28) at this time point [33]. The
threshold for viral load suppression ranged from less than 100 copies/mL [23], to 1,000 copies/
mL [28]. In one study, viral suppression in the community ART arm was higher when data
Fig 4. ART retention at 6–12 months among HIV-positive individuals. COM, community ART initiation; e, number of events; n, number of
participants; RCT, randomized controlled trial; RR, risk ratio; SOC, standard of care. MacPherson 2014 reflects cluster-adjusted numbers based
on the Cochrane method of adjusting for the design effect.
https://doi.org/10.1371/journal.pmed.1003646.g004
Fig 5. ART retention at 6–12 months among HIV-positive individuals, by implementation strategy. COM, community ART
initiation; FSW, female sex workers; ND, not determined; RR, risk ratio; SOC, standard of care. MacPherson 2014 reflects cluster-
adjusted numbers based on the Cochrane method of adjusting for the design effect.
https://doi.org/10.1371/journal.pmed.1003646.g005
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were restricted to men from a South African subgroup (RR 1.39, 95% CI 1.17 to 1.66) [25].
Meta-analysis of viral suppression restricted to those who initiated ART showed no difference
in viral suppression between treatment arms at 12 months (RR 1.05, 95% CI 0.86 to 1.29) (S7
Fig).
Two studies compared community ART initiation with hybrid community–facility ART
strategies, including either facility-based ART initiation or facility-based ART refill (Table 5).
One compared community ART initiation and refills versus facility ART initiation with com-
munity ART refills [24,25] and found no difference in viral suppression between these 2 strate-
gies. When analysis was restricted to the South African male subgroup, community ART
initiation and maintenance appeared to have better viral suppression than if ART was initiated
at the facility and maintained in the community (RR 1.26, 95% CI 1.04 to 1.51) in this study.
Another study compared 2 community ART initiation strategies, one with ART refills deliv-
ered in the community versus another with refills collected at the health facility; this compari-
son showed no difference in viral suppression at 12 months between refill strategy arms (RD
−7%, 95% CI −20% to 6%) [27].
ART adherence
There was no difference in ART adherence among ART initiators at 6 months in the 2 studies
contributing to this comparative analysis (RR 0.92, 95% CI 0.84 to 1.02) (Fig 7). Adherence
was assessed as not missing a single dose in the past 4 days [26] or not missing a dose in the
past 7 days as assessed by self-report [28].
Fig 6. Viral suppression among HIV-positive individuals at 12 months: Community ART initiation versus facility-based care. COM,
community ART initiation; e, number of events; n, number of participants; RCT, randomized controlled trial; RR, risk ratio; SOC, standard of
care.
https://doi.org/10.1371/journal.pmed.1003646.g006
Table 5. Viral suppression among HIV-positive individuals at 12 months: Community ART initiation and refill versus community–facility hybrid initiation and
refill strategies.
Study Community ART Hybrid community–facility ART Effect estimate, 95% CI
ART initiation ART refill site ART initiation ART refill site
Barnabas 2020 Community Community Facility Community RR 1.08, 95% CI 0.98 to 1.19
Amstutz 2021 Community Community Community Facility RD −7%, 95% CI −20% to 6%
RD, risk difference; RR, risk ratio.
https://doi.org/10.1371/journal.pmed.1003646.t005
PLOS MEDICINE Community ART initiation: A systematic review
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1003646 May 28, 2021 13 / 22
Mortality
Overall, there were few events contributing to this outcome. Three studies contributed to the
comparative analysis of mortality (at 6 to 12 months), showing no difference in mortality
among those who initiated ART in the community compared with those who initiated in the
health facility (Fig 8; RR 2.37, 95% CI 0.56 to 10.05). The Ibiloye 2018 study reported overall
mortality in its community ART non-comparative cohort study at 3, 6, and 9 months on ART
as 3.4%, 3.7%, and 3.9%, respectively. Additionally, Amstutz et al. reported 5% (6/118) mortal-
ity in the community ART initiation and refill arm, compared to 0% (0/139) mortality in the
hybrid community ART initiation and facility refill arm [27].
Adverse events and social harms
There was variable adverse event reporting, including mild, serious, and severe adverse events,
social harms, and opportunistic infection incidence (Table 6). Severe adverse events in com-
munity ART initiation arms ranged from 1% to 6% and in facility ART initiation arms ranged
from 1% to 2% [23,25,30,33]. There were very few opportunistic infections or social harms;
this was however infrequently reported in the included studies.
Certainty of review findings (GRADE assessment)
The certainty of the evidence (a combined assessment of strength of association, methodologi-
cal quality, heterogeneity, and external validity) for the pooled (RCT and cohort) data on
Fig 7. ART adherence among ART initiators at 6 months. COM, community ART initiation; e, number of events; n, number of
participants; RR, risk ratio; SOC, standard of care. MacPherson 2014 reflects cluster-adjusted estimates based on the Cochrane method of
adjusting for the design effect.
https://doi.org/10.1371/journal.pmed.1003646.g007
Fig 8. Mortality among HIV-positive individuals at 12 months. COM, community ART initiation; e, number of events; n, number of participants; RCT,
randomized controlled trial; RR, risk ratio; SOC, standard of care.
https://doi.org/10.1371/journal.pmed.1003646.g008
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primary outcomes of uptake, retention, and viral suppression among HIV-positive individuals
was graded as low to moderate (Table 7); effect estimates were downgraded due to high risk of
bias in the contributing observational studies (Table 7). Pooled estimates for adherence were
similarly graded as low certainty evidence, due to the inclusion of self-reported outcomes and
poor methodological quality. Very few events contributed to the mortality analysis, resulting
in very low certainty evidence for this outcome.
Implementation outcomes
Few studies reported on implementation outcomes of community ART initiation, 2 studies
reported on cost, and no studies reported on acceptability, penetration, adoption, fidelity,
adaptations, feasibility, or sustainability related to community ART initiation.
Of the 2 studies reporting on costs, one reported on the community ART initiation arm
only [26], and the second reported cost comparisons of facility ART initiation and community
ART initiation across 3 study settings [25]. The Barnabas 2020 study demonstrated some vari-
ability across settings, with the cost per person virally suppressed higher with community-
based ART initiation compared to facility ART initiation in 2 of the settings (Table 8).
Ongoing studies
We identified 3 ongoing studies being conducted in Indonesia [38], Zimbabwe [39], and
Puerto Rico [40]. One study includes adolescents, and 2 studies include key population groups
(S3 Table).
Discussion
In this systematic review, we found that making ART initiation available in the community led
to increases in ART uptake, better retention, and improved viral suppression (over the course
Table 6. Adverse events among HIV-positive.
Study Adverse events Opportunistic infections Social harms












6 (4%) events—2 rash, 1 nausea, 1
dizziness, 1 gynecomastia, 1 elevated
alanine aminotransferase level
2 events (1%)—2 rash 0 TB cases 2 (1%) TB
cases
— —







7 (1%) severe and 7 (1%) serious adverse
events
8 (2%) severe and 2
(0.4%) serious
adverse events
— — 2 events 0 events
Barnabas
2020 (b)
— 5 (1%) severe and 4
(1%) serious adverse
events
— — — 0 events
Amstutz
2021 (a)
7 (6%) events—serious adverse events — — — — —
Amstutz
2021 (b)
7 (3%) events—serious adverse events — — — — —
Barnabas 2020 (a): community ART initiation arm combined with community ART refills. Barnabas 2020 (b): community ART initiation arm combined with facility
ART refills. Amstutz 2021 (a): community ART initiation combined with community ART refills. Amstutz 2021 (b): community ART initiation combined with facility
ART refills.
https://doi.org/10.1371/journal.pmed.1003646.t006
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of 1 year after ART offer), compared to traditional facility-based ART initiation. Models offer-
ing ART initiation in the community increased uptake by 30% and 1-year retention by 19%
compared to initiation and maintenance at a traditional health facility. This finding of higher
ART uptake in the community ART arm was consistent across study designs and various
implementation methods. In one head-to-head comparison of alternative ART refill distribu-
tion strategies after community ART initiation, 1-year retention and viral suppression was
comparable between community ART refill and facility refill. Another study measured 2-year
Table 7. Review evidence certainty assessment (GRADE): Community ART initiation versus facility ART initiation.






Study design Risk of
bias




ART initiation among PLWH
5 RCTs and
observational
























Retention in care among PLWH at 6–12 months
4 RCTs and
observational




















Retention in care among PLWH at 24 months
1 RCT Not
serious
Not serious Not serious Very
seriousc





Viral suppression among PLWH at 12 months
3 RCTs and
observational




















Viral suppression among PLWH at 24 months
1 RCT Not
serious
Not serious Not serious Very
seriousc






Adherence among ART initiates at 6 months
2 RCTs and
observational






Mortality among PLWH at 6–12 months
3 RCTs and
observational
Seriousa Not serious Not serious Very
seriousc




PLWH, people living with HIV; RCT, randomized cont rolled trial; RD, risk difference; RR, risk ratio.
aIncluded observational studies that have methodological concerns—comparison groups drawn from different populations and baseline imbalances were not accounted
for in the analysis.
bI2 statistic >90%
cFew studies and events
https://doi.org/10.1371/journal.pmed.1003646.t007
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outcomes and found viral suppression and retention to be no different at this time point
between those offered ART initiation in the community and those offered facility initiation.
There were too few events to confidently determine the effect of community ART initiation on
adherence and mortality. Similarly, few studies reported on adverse events or social harms.
These findings were based on the synthesis of 8 studies conducted primarily in low- and mid-
dle-income African countries with high to moderate HIV burden, representing diversity in
geographical locations and population groups in these settings.
The effect of community-based models for initiating ART had consistent effects across
implementation strategies and population subgroups. Community ART was provided through
a variety of distribution models: ART was provided at home, in mobile vans and tents, or at
community locations; ART was initiated by large multidisciplinary teams in some studies, and
in others was primarily nurse driven; and ART refills were subsequently distributed either in
the community or at health facilities. In comparative analyses, community ART initiation was
explored in general HIV endemic communities, men, adolescents, and FSWs, and in one
study was seen to be particularly beneficial for men—suggesting that this may be an additional
strategy for improving engagement in HIV services for men, who do not routinely attend
health services [8,41]. Among key populations, ART uptake was modest, with the lowest
uptake reported in PWID; however, comparative analyses also showed improved treatment
outcomes for these groups compared to facility-based offer of ART. Future studies focused on
population subgroups could help clarify which implementation strategies are most effective, in
which settings, and for whom.
Community ART initiation has the potential to expand differentiated service delivery mod-
els and move the entire HIV care cascade into the community, a service delivery approach that
both addresses structural barriers to attending health services for people living with HIV
(PLWH) and is highly relevant during the COVID-19 pandemic, when decongesting health
Table 8. Cost analyses reported in included studies.








Community ART initiation (60.3%), staff training (0.6%),
community sensitization (0.5%), drugs (3%), consumables (13.8%),













Cost of ART, trimethoprim-sulfamethoxazole, laboratory testing,












Cost of ART, trimethoprim-sulfamethoxazole, laboratory testing,












Cost of ART, trimethoprim-sulfamethoxazole, laboratory testing,





Annual cost per person
virally suppressed
$214 $275
aMidlands Kwazulu-Natal, South Africa.
bNorthern Kwazulu-Natal, South Africa.
https://doi.org/10.1371/journal.pmed.1003646.t008
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services has become critical—widespread scale-up, however, needs careful consideration.
Although the studies in this review were relatively pragmatic in their design, implementation
by external partners, additional resources, technical and logistical assistance, and training pro-
vided by research teams may mean that more modest outcomes will be seen when these strate-
gies are incorporated into large-scale public health programs with more limited resources [7].
Lessons can be learned from the implementation of community ART models for “stable” HIV-
positive people, which demonstrated effectiveness in trials, but when brought to scale
highlighted some of the challenges of bringing services into the community, including difficul-
ties with maintaining the ART supply chains, inadequate resources to support community-
based staff, patient concerns regarding HIV-related stigma in the community, and patient
preferences for facility-based care in some instances [42–45].
The mechanism by which offering ART in the community improves retention and viral
suppression appears to be through greater ART uptake and reduced loss to follow-up prior to
ART initiation. Once ART has been initiated, outcomes are similar to those of individuals who
initiate ART at a health facility. Analyses of the effect of offering ART to all PLWH on reten-
tion and viral suppression compared to analyses that were restricted to only those who initi-
ated ART showed remarkably improved retention and viral suppression at 1 year in the
former compared to smaller differences between community and facility arms in the latter.
This suggests that expanding the number of PLWH who initiate ART by offering initiation in
the community could have a substantial impact on reaching ART coverage goals, if these
effects can be reproduced at scale [46].
Few studies included in this review assessed implementation outcomes beyond cost. Addi-
tional study findings regarding fidelity to intervention protocols, challenges and required
adaptations, explorations of variability in PLWH and provider preferences and acceptability,
provider and health system adoption, and sustainability could aid future implementation and
should be incorporated into future study design and reporting [47–50].
Our review findings were limited by there being few studies for inclusion, the incorporation
of observational data of poor methodological quality, and short-term HIV treatment outcome
measures. For systematic reviews evaluating implementation strategies, the inclusion of obser-
vational and programmatic data is critical; however, in order to generate robust and relevant
synthesized results, high-quality evidence is needed. Assessments of the methodological quality
of observational studies included in this review showed observational studies to be of low qual-
ity according to risk of bias tools; this was in large part due to the inclusion of data with
observed baseline imbalances in participant characteristics between intervention and compari-
son groups. Although some studies conducted analyses (e.g., interrupted time series) to adjust
for selection, these model outputs could not be included in meta-analyses, and therefore raw
unadjusted data were pooled with RCT data [29]. Results from observational studies were
however consistent with RCT effects, with no differences between study design subgroup esti-
mates, supporting the pooling of these results. The majority of studies reported HIV treatment
outcomes at 1 year or less, with the exception of one study, where 2-year viral suppression
showed more moderate treatment outcomes as compared to outcomes at 1 year [33]; it is
therefore difficult to draw conclusions on the long-term outcomes of offering ART initiation
in the community.
Based on data from a limited set of studies, community ART initiation appears to increase
ART uptake and as a result shows better viral suppression and retention in care compared to
facility ART initiation and refill. Future research should explore which community ART initia-
tion and refill models are most effective for specific populations, evaluate strategies outside of
the African context, and report on long-term and implementation outcomes, to facilitate the
incorporation of these strategies into HIV programs.
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